Purchases and Sales Made in Q4 2021 in Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX) during Q4 2021. The information is specifically focused on institutions that hold shares of Lineage Cell Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2022
Q4 2021
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-96.8KClosed |
$178K - $259K
|
0
$0
|
|
Feb 10, 2022
Q4 2021
|
Citigroup Inc
|
SELL
|
- |
-102K- 74.17% |
$188K - $274K
|
35.6K
$24.2K
|
|
Feb 14, 2022
Q4 2021
|
Laidlaw Wealth Management LLC
New York City, NY |
SELL
|
- |
-105KClosed |
$193K - $281K
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
SELL
|
- |
-168K- 80.77% |
$309K - $450K
|
39.9K
$27.2K
|
|
Feb 14, 2022
Q4 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-180K- 25.5% |
$330K - $481K
|
525K
$357K
|
|
Feb 02, 2022
Q4 2021
|
Deka Bank Deutsche Girozentrale
|
SELL
|
- |
-185K- 33.55% |
$339K - $494K
|
366K
$249K
|
|
Feb 10, 2022
Q4 2021
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-194KClosed |
$357K - $519K
|
0
$0
|
|
Feb 11, 2022
Q4 2021
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-359KClosed |
$661K - $963K
|
0
$0
|
|
Feb 08, 2022
Q4 2021
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-417K- 27.82% |
$767K - $1.12M
|
1.08M
$735K
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-933K- 42.08% |
$1.72M - $2.5M
|
1.28M
$873K
|
|
Feb 14, 2022
Q4 2021
|
State Street Corp
Boston, MA |
SELL
|
- |
-3.38M- 62.0% |
$6.23M - $9.07M
|
2.07M
$1.41M
|